Orphazyme Wants More Time To Deal With Late-Stage Issues For Arimoclomol In EU

Other Sponsors Also Ask For A Longer Pause To CHMP’s Review Clock

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".